172 related articles for article (PubMed ID: 2884347)
1. The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon--studies with cultured heart cells.
Reithmann C; Thomschke A; Werdan K
Klin Wochenschr; 1987 Apr; 65(7):308-16. PubMed ID: 2884347
[TBL] [Abstract][Full Text] [Related]
2. Endogenous noradrenaline and beta-adrenoceptor regulation in cultured heart cells.
Reithmann C; Thomschke A; Werdan K
Biomed Biochim Acta; 1987; 46(8-9):S628-33. PubMed ID: 2829873
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic sympathomimetic activity of beta-adrenoceptor antagonists: down-regulation of cardiac beta 1- and beta 2-adrenoceptors.
Reithmann C; Wieland F; Jakobs KH; Werdan K
Eur J Pharmacol; 1989 Nov; 170(3):243-55. PubMed ID: 2575997
[TBL] [Abstract][Full Text] [Related]
4. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
Williamson KL; Broadley KJ
Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
6. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
[TBL] [Abstract][Full Text] [Related]
7. Differential recruitment of alpha 1- and beta-adrenoceptors in inotropic control of atrial child myocardium by endogenous noradrenaline.
Borthne K; Langslet A; Lindberg H; Skomedal T; Osnes JB
Acta Physiol Scand; 2000 Sep; 170(1):21-31. PubMed ID: 10971219
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of beta-blockers: classical aspects and recent developments.
Haeusler G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
[TBL] [Abstract][Full Text] [Related]
9. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
[TBL] [Abstract][Full Text] [Related]
10. Increased number of beta-adrenoceptors in cultured heart cells after propranolol withdrawal.
Fukunaga H; Saito K; Tanaka H
Jpn Heart J; 1990 Sep; 31(5):693-701. PubMed ID: 2177112
[TBL] [Abstract][Full Text] [Related]
11. Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.
Giudicelli Y; Lacasa D; Agli B; Leneveu A
Eur J Clin Pharmacol; 1984; 26(1):7-12. PubMed ID: 6325205
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac beta receptors--experimental aspects].
Kaumann AJ
Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
[TBL] [Abstract][Full Text] [Related]
13. Beta adrenergic receptor blockade of feline myocardium. Cardiac mechanics, energetics, and beta adrenoceptor regulation.
Cooper G; Kent RL; McGonigle P; Watanabe AM
J Clin Invest; 1986 Feb; 77(2):441-55. PubMed ID: 2868025
[TBL] [Abstract][Full Text] [Related]
14. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
[TBL] [Abstract][Full Text] [Related]
15. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
18. Antagonism between T3 and amiodarone on the contractility and the density of beta-adrenoceptors of chicken cardiac myocytes.
Yin Y; Vassy R; Nicolas P; Perret GY; Laurent S
Eur J Pharmacol; 1994 Aug; 261(1-2):97-104. PubMed ID: 8001659
[TBL] [Abstract][Full Text] [Related]
19. Relative potencies of various beta-adrenoceptor antagonists (BAA) at the level of the human myocardial beta-adrenoceptor-adenylate cyclase (AC) complex. Is intrinsic sympathomimetic activity (ISA) due to AC activation?
Golf S; Hansson V
Scand J Clin Lab Invest; 1986 Apr; 46(2):121-30. PubMed ID: 2872714
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
Ferro A; Hall JA; Dickerson JE; Brown MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
